NYMC Faculty Publications

Neprilysin Inhibition and the Treatment of Heart Failure: Recent Steps in the Right Direction

DOI

10.1097/CRD.0000000000000169

Journal Title

Cardiology in Review

First Page

315

Last Page

320

Document Type

Article

Publication Date

11-1-2017

Department

Medicine

Abstract

Numerous investigators have attempted to target the natriuretic peptide system in the treatment of heart failure since it was first described over 30 years ago. The history of neprilysin inhibition as a treatment for heart failure has been characterized by numerous setbacks. Recently, the PARADIGM-HF trial has shown favorable results, which may bring neprilysin inhibition into the mainstream of clinical practice. This article will review the history of the natriuretic peptide system and the investigations into it as a target for heart failure treatment, culminating in the positive results of the PARADIGM-HF trial, as well as planned and potential future directions for research.

Link to Full Text

Share

COinS